Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Open-Label Extension Study of Saroglitazar Magnesium in Participants With Primary Biliary CholangitisDigestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bile duct disorder, biliary tract disorder, cholestasis, cirrhosis of liver, intrahepatic cholestasis, liver disorder, primary biliary cholangitisActive, not recruitingPhase 32026-05-12NCT06427395

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Zydus Therapeutics Inc.6

28 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Zydus AR001Ciudad Autónoma de Buenos AiresArgentina1
Zydus AR003Ciudad Autónoma de Buenos AiresArgentina1
Zydus AR004PilarArgentina1
Zydus AR005Ciudad Autónoma de Buenos AiresArgentina1
Zydus AR006Ciudad Autónoma de Buenos AiresArgentina1
Zydus AR007Ciudad Autónoma de Buenos AiresArgentina1
Zydus TR004AnkaraTurkey (Türkiye)1
Zydus TR005BursaTurkey (Türkiye)1
Zydus TR015MelikgaziTurkey (Türkiye)1
Zydus TR016AltındağTurkey (Türkiye)1
Zydus TR017CebeliTurkey (Türkiye)1
Zydus US001IndianapolisUnited States1
Zydus US002CharlotteUnited States1
Zydus US005MiamiUnited States1
Zydus US006Lakewood RchUnited States1
Zydus US011PasadenaUnited States1
Zydus US013Los AngelesUnited States1
Zydus US016CharlottesvilleUnited States1
Zydus US020MariettaUnited States1
Zydus US022AuroraUnited States1
Zydus US027JacksonvilleUnited States1
Zydus US031MurrayUnited States1
Zydus US033SeattleUnited States1
Zydus US035RochesterUnited States1
Zydus US037New HavenUnited States1